Pitfalls in Statistics - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

 Pharmaceutical Technology All results
Pitfalls in Statistics
The hardest errors to spot are the ones that don't look like errors at all.
 Apr 2, 2011 Pharmaceutical Technology Volume 35, Issue 4, pp. 40-42
 Assay results. Correcting or adjusting one assay result with the result of a second assay that has the same as or larger variance than the first will result in more total variability, not less, because the variances add up. This is known as the "weight to run" problem, in which tablet weight is adjusted using an assay test for potency. This problem can lead to rejecting good lots of materials and products. In most cases, setting the weight equal to the target results in less variation. Population paremeters. Recognize that the population parameters, such as mu (µ), the population mean, and sigma (σ), the population standard deviation, are single values, whereas sample estimates of the population mean and sample estimates of the population standard deviation are random results from a distribution. Every additional sample gives slightly different results, so problems arise when sample estimates are treated as if they are population values. This leads to treating other sample estimates such as %RSD and Cpk as if they are without variation. Confidence intervals should be calculated for these statistics to estimate their uncertainty. Definitions and intervals. Define in exact detail what the phrase "within the variation of the method" means for specific applications because there is no universally accepted definition. Try not to use use confidence intervals to set specification criteria. Instead, use tolerance intervals to get a starting point. Overlapping or non-overlapping confidence intervals are not a significance test. The most egregious pitfall of all is calculating the sample average plus and minus three times the sample standard deviation without considering the sample size and distribution, and then using it for confidence intervals, setting specification criteria, identifying outliers and all other manner of ad-hoc comparisons. It is not a universal statistical tool. In fact, this equation came about in the 1920s via Dr. Walter Shewhart for defining control charts and is no longer of much use today. Of course, there are many more potential pitfalls, and when in doubt, contact your local statistician. Lynn D. Torbeck is a statistician at Torbeck and Assoc., 2000 Dempster Plaza, Evanston, IL 60202, tel. 847.424.1314, Lynn@Torbeck.org, http://www.torbeck.org/. References 1. L. D. Torbeck, "Analytical Validation" supplement to Pharm. Technol. 23, 21-23 (1999). 2. M. Spiegel and L. Stephens, Schaum's Outline of Statistics Fourth Edition (McGraw Hill, NY, NY, 2008). 3. E. R. Tufte, The Visual Display of Quantitative Information (Graphics Press, Cheshire, CT, 1983).
 ADVERTISEMENT
blog comments powered by Disqus

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly
 Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products 20%
To all process for new products only 13%
To select process for new products only 25%
To select processes for both new and legacy products 20%
Do not use QbD 23%
Most Viewed Articles
 UPCOMING CONFERENCES Programs for Investigational and Pre-Launch Drugs Philadelphia, PA July 17-18, 2013 Request Brochure Strategic Pipeline Planning & Portfolio Valuation Philadelphia, PA August 13-14, 2013 Request Brochure MES 2013 - Forum on Manufacturing Execution Systems Philadelphia, PA August 14-15, 2013 Request Brochure Mobile Innovation for the Life Sciences Industry Philadelphia, PA August 20-21, 2013 Request Brochure See All Conferences >>
 Columnists sponsored by Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy sponsored by Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry sponsored by Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
Click here